Tuberous Sclerosis Complex Research Program Funding Opportunities for Fiscal Year 2023
The FY23 Defense Appropriations Act is anticipated to provide funding for the TSCRP to support innovative, high-impact tuberous sclerosis complex (TSC) research. The managing agent for the anticipated funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command (USAMRDC). The FY23 TSCRP funding opportunity announcements for the following award mechanisms are posted on the Grants.gov website.
Advanced Research Projects Agency for Health (ARPA-H) Funding Announcement
The mission of ARPA-H is to accelerate better health outcomes for everyone by supporting the development of high-impact solutions to society’s most challenging health problems. Awardees will develop groundbreaking new ways to tackle health-related challenges through highpotential, high-impact biomedical and health research. With a scope spanning the molecular to the societal, ARPA-H seeks proposals that aim to rapidly achieve better health outcomes across patient populations, communities, diseases, and health conditions, including in support of the Cancer Moonshot. Proposals are expected to use innovative approaches to enable revolutionary advances in science, technology, or systems.
Early-Stage Investigator Research Grants & Postdoctoral Fellowships
The TSC Alliance is dedicated to finding a cure for tuberous sclerosis complex (TSC) while improving the lives of those affected. We invest in early-career researchers to drive innovative TSC research and to foster a diverse group of researchers dedicated to our shared mission. In 2023, we anticipate awarding three or four awards to postdoctoral fellows and early-stage investigators depending on merit, requested budgets, and funds available.
American Epilepsy Society Research Grant Opportunities
The American Epilepsy Society (AES) is proud to support established investigators working in basic, translational, and clinical research for epilepsy, seizures, and related disorders.
Request for Applications for the Simons Foundation Independence Awards
The Simons Foundation is committed to supporting scientists as they transition from mentored training to their first independent research positions. To that end, the foundation offers three independence awards through its Simons Foundation Autism Research Initiative (SFARI), Simons Collaboration on the Global Brain (SCGB) and Simons Collaboration on Plasticity and the Aging Brain (SCPAB).
TSCRP Anticipated Funding Opportunities for Fiscal Year 2023
The FY23 Defense Appropriations Act is anticipated to provide funding for the TSCRP to support innovative, high-impact tuberous sclerosis complex (TSC) research. The managing agent for the anticipated funding opportunities is the CDMRP at the US Army Medical Research and Development Command (USAMRDC).
Developmental Synaptopathies Consortium Request For Pilot Project Applications
Overview: The pilot feasibility core of the Developmental Synaptopathies Consortium (DSC) is pleased to announce that it will fund an estimated $40,000 total costs for a pilot project to stimulate additional research through the DSC NIH grant for one of the following disorders: Tuberous Sclerosis Complex (TSC), PTEN Hamartoma Syndrome (PHTS) and Phelan-McDermid Syndrome (PMS). The funding will be coordinated, dispersed and evaluated for progress through the DSC infrastructure.
Deadline Friday: TSC Biosample Seed Grants Available
The TSC Alliance announces a funding opportunity for 2022 Biosample Seed Grants to support research using blood, tissue, and/or cells, DNA, or RNA isolated from samples in the TSC Biosample Repository. The award may support laboratory supplies, personnel costs, services, or equipment necessary to conduct the proposed research. Funds requested can be up to $20,000. Funding period is one year. The TSC Biosample Repository houses human biological materials linked to detailed clinical data in the TSC Natural History Database. High-quality biosamples and their associated clinical data enable researchers to discover biomarkers, establish human cell lines or tissue arrays for drug testing, and…
Funding Opportunity for SUDEP Research and Prevention
In partnership with the American Epilepsy Society, Partners Against Mortality in Epilepsy (PAME) desires to fund ideas that advance SUDEP Summit priorities using the AES Seed Grants mechanism. This grant program offers funds to enable established investigators to pursue new and innovative lines of research, collaborations, and/or research methods. A goal of the seed grant program is to help these investigators lay the groundwork for another grant that would help continue research. Funds can be used for planning purposes and pilot projects. Specifically, PAME is interested in funding projects to advance clinical action priorities that will impact SUDEP prevention in the next…
TSC Biosample Seed Grants Available
The TSC Alliance announces a funding opportunity for 2022 Biosample Seed Grants to support research using blood, tissue, and/or cells, DNA, or RNA isolated from samples in the TSC Biosample Repository. The award may support laboratory supplies, personnel costs, services, or equipment necessary to conduct the proposed research. Funds requested can be up to $20,000. Funding period is one year. The TSC Biosample Repository houses human biological materials linked to detailed clinical data in the TSC Natural History Database. High-quality biosamples and their associated clinical data enable researchers to discover biomarkers, establish human cell lines or tissue arrays for drug testing, and…